Does the addition of a prokinetic to proton pump inhibitor therapy help reduce duodenogastro-oesophageal reflux in patients with Barrett's oesophagus?

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 3, 2003, Pages 305-312

  Smythe, Anne ^a,b   Bird, Nigel C ^a   Troy, Gill P ^a   Ackroyd, Roger ^a   Johnson, Alan G ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Barrett's oesophagus; Duodenogastro oesophageal reflux; Oesophageal motility

Indexed keywords

CISAPRIDE; OMEPRAZOLE; PLACEBO; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DUODENOGASTRIC REFLUX; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; HUMAN; MALE; METAPLASIA; PERISTALSIS; PH MEASUREMENT; PRIORITY JOURNAL; STOMACH ACID; TREATMENT OUTCOME;

ADULT; AGED; ANTI-ULCER AGENTS; BARRETT ESOPHAGUS; CISAPRIDE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DUODENOGASTRIC REFLUX; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; PERISTALSIS; PROTON PUMPS;

EID: 0037340540     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200303000-00014     Document Type: Article

References (36)

1. Barrett NR. Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg 1950; 38:175-182.
2. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the oesophagus and gastric cardia. JAMA 1991; 265:1287-1289.
3. Hamilton ST, Smith RR. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma. Am J Clin Pathol 1987; 87:301-312.
4. Jankowski J, Harrison R, Perry I, Balkwill F, Tselpis C. Barrett's metaplasia. Lancet 2000; 356:2079-2085.
5. Parrilla P, Ortiz A, Martinez de Haro LF. Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus. Gut 1990; 31:964-967.
6. Neumann CS, Cooper BT. 24 hour ambulatory oesophageal pH monitoring in uncomplicated Barrett's oesophagus. Gut 1994; 35:1352-1355.
7. Harmon JW, Johnson LF, Maydonovitch CL. Effects of acid and bile salts on the rabbit esophageal mucosa. Dig Dis Sci 1981; 26:65-72.
8. Vaezi ME, Richter JE. Role of acid and duodeno-gastro-esophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996; 111:1192-1199.
9. Vaezi MF, Richter JE. Synergism of acid and duodeno-gastro-esophageal reflux in complicated Barrett's oesophagus. Surgery 1994; 117:699-704.
10. Marshall REK, Anggiansah A, Owen WJ. Bile in the oesophagus: clinical relevance and ambulatory detection. Br J Surg 1997; 84:21-28.
11. Nehra D, Howell P, Pye JK, Benon J. Assessment of combined bile acid and pH profiles using an automated sampling device in gastro-oesophageal reflux disease. Br J Surg 1998; 85:134-137.
12. Smythe A, Bird N, Troy G, Globe J, Johnson AG. Effect of cisapride on oesophageal motility and duodeno-gastro-oesophageal reflux in patients with Barrett's oesophagus. Eur J Gastroenterol Hepatol 1997; 9:1-5.
13. Smythe A, Bird N, Johnson AG. Continuous monitoring of sodium ion concentration in the human stomach - a new technique for the detection of duodenogastric reflux. Digestion 1992; 52:20-25.
14. Sharma P, Sampliner RE, Camargo E. Normalisation of oesophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's oesophagus. Am J Gastroenterol 1997; 92:582-585.
15. Wetscher GJ, Profanter C, Gadenstatter M, Perdikis G, Glaser K, Hinder RA. Medical treatment of gastroesophageal reflux disease does not prevent the development of Barrett's metaplasia and poor oesophageal body motility. Langenbecks Arch Chir 1997; 382:95-99.
16. De Meester SR, De Meester TR. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 2000; 231:303-321.
17. Sampliner RE, Garewal HS, Fennerty MB, Aickin M. Lack of impact of therapy on extent of Barrett's oesophagus in 67 patients. Dig Dis Sci 1990; 35:93-96.
18. Salo J, Salimen J, Kiviluoto T, Nemlander A, Ramo J, Farkkila M, et al. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg 1998; 227:40-44.
19. Paterson WG, Wang H, Beck IT. The effect of cisapride in patients with reflux esophagitis: an ambulatory esophageal manometry/pH-metry study. Am J Gastroenterol 1997; 92:226-230.
20. Vaezi MF, Sears R, Richter JE. Placebo-controlled trial of cisapride in postgastrectomy patients with duodenogastroesophageal reflux. Dig Dis Sci 1996; 41:754-763.
21. Rezende-Filho J, Di Lorenzo C, Dooley C, Valenzuela JE. Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia. Dig Dis Sci 1989; 34:1057-1062.
22. Szarszewski A, Korzon M, Kaminska B, Lass P. Duodenogastric reflux: clinical and therapeutic aspects. Arch Dis Child 1999; 81:16-20.
23. Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, et al. A comparison of five maintenance therapies for reflux oesophagitis. N Engl J Med 1995; 333:1106-1110.
24. Watson DI, Smythe A, Mangnall Y, Johnson AG. The detection of duodenal fluid in the oesophagus with a sodium ion selective electrode. J Gastroenterol Hepatol 1996; 11:486-490.
25. Smythe A, Bird NC, Troy GP, Johnson AG. Oesophageal reflux of duodenal contents in symptomless controls. A combined study with ambulatory manometry. Neurogastroenterol Motil 1998; 10:432.
26. Smythe A, Bird NC, Troy GP, Johnson AG. In Barrett's oesophagus patients, reduction in acid reflux is linked to improved oesophageal motility when a prokinetic is added to a PPI. Neurogastroenterol Motil 2001; 13:432.
27. Okholm M, Sorensen H, Wallin L, Boesby S. Bile reflux into the esophagus. Scand J Gastroenterol 1999; 34:653-657.
28. Marshall REK, Anggiansah A, Manifold DK, Owen WA, Owen WJ. Effect of omeprazole 20mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus. Gut 1998; 43:603-606.
29. Vinter-Jensen L, Kraglund K, Pederson SA. A double blind placebo controlled trial on characteristics of the migrating motor complex in healthy volunteers. Aliment Pharmacol Ther 1989; 3:615-620.
30. Rasmussen L, Oster-Jorgensen E, Qvist N, Kraglund K, Hovendal C, Pedersen SA. Short report: a double blind placebo controlled trial of omeprazole on characteristics of gastric emptying in healthy subjects. Aliment Pharmacol Ther 1991; 5:85-89.
31. Benini L, Castellani G, Bardelli E, Sembenini C, Brentegani MT, Caliari S, Vantini I. Omeprazole causes delay in gastric emptying of meals. Dig Dis Sci 1996; 41:469-474.
32. Smythe A, Bird NC, Troy G, Greaves C. Acid reflux on maintenance dose PPIs. Further evidence of a motility defect in Barrett's oesophagus. Gut 1999; 45 (suppl V):A165.
33. Inauen W, Emde C, Weber B, Armstrong D, Bettschen HU, Huber T, et al. Effect of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study. Gut 1993; 34:1025-1031.
34. Holloway RH, Penagini R, Schoeman MN, Dent J. Effect of cisapride on secondary peristalsis in patients with gastroesophageal reflux disease. Am J Gastroenterol 1999; 94:799-803.
35. Corazziari E, Bontempo I, Anzini F. Effects of cisapride on distal esophageal motility in humans. Dig Dis Sci 1989; 34:1600-1605.
36. Vitola J, Vukanovic J, Roden DM. Cisapride-induced torsade de pointes. J Cardiovasc Electrophysiol 1998; 9:1109-1113.